{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_9283265_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"136-708-914-238-185","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11681,"type":"PATENT","title":"Weizmann Institute of Science - Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":8051,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8337,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:weizma* inst*
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 8079
Search Applicants and Owners separately:weizma* inst*
Select more for logical variants.
Add to collection.
Select all patents in the collection and expand by simple families.
Add to collection. Total patents: 8079
administering by intramuscular injection to an individual having an inflammatory bowel disease a composition comprising a nucleic acid molecule encoding a mammalian heat shock protein 90 (HSP90), or an active fragment thereof, in an amount effective to provide for a shift to a Th2 immune response in the individual, wherein the nucleic acid molecule is operatively linked to one or more transcription control sequences,\n
wherein the administering treats the inflammatory bowel disease in the individual."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the composition comprises a delivery vehicle selected from the group consisting of liposomes, micelles, and emulsions."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the composition comprises about 0.1 μg/kg body weight to about 200 μg/kg body weight of the nucleic acid molecule encoding the mammalian HSP90, or an active fragment thereof."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the inflammatory bowel disease is ulcerative colitis."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the inflammatory bowel disease is Crohn's disease."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the mammalian HSP 90 is human HSP90."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the individual is a human."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the composition comprises about 0.1 μg/kg body weight to about 10 μg/kg body weight of the nucleic acid molecule encoding the mammalian HSP90, or an active fragment thereof."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["A method of treating inflammatory bowel disease in an individual, the method comprising:\n
administering by intramuscular injection to an individual having an inflammatory bowel disease a composition comprising about 0.1 μg/kg body weight to about 200 μg/kg body weight of a nucleic acid molecule encoding mammalian heat shock protein HSP90, wherein the nucleic acid molecule is operatively linked to one or more transcription control sequences,\n
wherein the administering treats the inflammatory bowel disease in the individual."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 9, wherein the composition comprises about 0.1 μg/kg body weight to about 10 μg/kg body weight of the nucleic acid molecule encoding the mammalian HSP90."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 9, wherein the inflammatory bowel disease is Crohn's disease."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 9, wherein the composition comprises a delivery vehicle selected from the group consisting of liposomes, micelles, and emulsions."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 9, wherein the inflammatory bowel disease is ulcerative colitis."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 9, wherein the HSP90 is human HSP90."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 9, wherein the individual is a human."],"number":15,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}